Adverse clinical outcomes associated with RAAS inhibitor discontinuation: analysis of over 400 000 patients from the UK Clinical Practice Research Datalink (CPRD)

Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19

(2020) Reinhold Kreutz et al.   CARDIOVASCULAR RESEARCH

Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

(2020) Patrick Rossignol et al.   EUROPEAN JOURNAL OF HEART FAILURE

Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate

(2020) Yao Qiao et al.   JAMA Internal Medicine

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

(2019) Michel Komajda et al.   EUROPEAN JOURNAL OF HEART FAILURE

Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

(2019) Cecilia Linde et al.   Journal of the American Heart Association

Risk of hyperkalemia from renin–angiotensin–aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population

(2019) James B Wetmore et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors

(2018) Juan Tamargo et al.   CARDIOVASCULAR DRUGS AND THERAPY

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink

(2018) Hans Furuland et al.   BMC Nephrology

How Dangerous Is Hyperkalemia?

(2017) John R. Montford et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project

(2017) Ghassan Bandak et al.   Journal of the American Heart Association

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function

(2015) J. Luo et al.   Clinical Journal of the American Society of Nephrology

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

(2014) Hazel Mae A. Abraham et al.   DRUG SAFETY

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

Major Barriers against Renin–Angiotensin–Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3–5 in Clinical Practice: A Safety Concern?

(2012) Tolga Yildirim et al.   RENAL FAILURE

The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease

(2009) A. K. Ahmed et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION